AnodyneWiki

Midazolam

Midazolam
Midazolam
Salts
[]
Midazolam hydrochloride
Midazolam hydrochloride
Midazolam maleate
Midazolam maleate
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass325.80 g/mol [1]
AppearanceColorless crystals from ether/methylene chloride/ hexane [1]
Melting point161-164 [1]
Boiling point496.9±55.0 [1]
DecompositionWhen heated to decomposition it emits toxic fumes of /hydrogen fluoride, hydrogen chloride and nitrogen oxides/. [1]
Solubility54mg/L [1]
Predicted LogP2.5 [1]
Structural Identifiers
[]
Molecular formulaC18H13ClFN3
IUPAC name8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
SMILESCC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F
InChIInChI=1S/C18H13ClFN3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3
InChIKeyDDLIGBOFAVUZHB-UHFFFAOYSA-N
CAS number59467-70-8
UNIIR60L0SM5BC
PubChem CID4192
Pharmacokinetics[]
OnsetWithin 5 min (IV), 15 min (IM), 20 min (oral)
Elimination half-life1.5–2.5 hours
Duration of action1–6 hours
MetabolismLiver: CYP3A3, CYP3A4, CYP3A5
ExcretionKidney
Routes of administrationBy mouth, intramuscular, intravenous, buccal, intranasal
Addiction liabilityModerate[3]
Toxicity
[]
Mouse:
- iv: 50 mg/kg
- oral: 1600 mg/kg
Rat:
- iv: 75 mg/kg
- oral: 1600 mg/kg
- Oral: 825 mg/kg
 [1]

Midazolam (also known as Buccolam, Midazolamum, mezolam, Nayzilam, Midazolam civ, Usl261, Usl-261, 8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin, 8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine or 4H-Imidazo(1,5-a)(1,4)benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-) is a anaesthetic and depressant substance of the imidazobenzodiazepine class.

Chemistry

Salts []

Midazolam is typically found in the form of its hydrochloride and maleate salts.

 []

Midazolam is achiral.

Midazolam matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

The actions of benzodiazepines such as midazolam are mediated through the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), which is one of the major inhibitory neurotransmitters in the central nervous system. Benzodiazepines increase the activity of GABA, thereby producing a sedating effect, relaxing skeletal muscles, and inducing sleep, anesthesia, and amnesia. Benzodiazepines bind to the benzodiazepine site on GABA-A receptors, which potentiates the effects of GABA by increasing the frequency of chloride channel opening. These receptors have been identified in different body tissues including the heart and skeletal muscle, although mainly appear to be present in the central nervous system. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

metabolism / inhibition / induction1558 (76 contraindicated)
shared target186
shared target178
shared target178
shared target178
shared target178
shared target178
shared target178
shared target178
shared target178
shared target178
shared target178
shared target178
shared target178
shared target178
shared target178
shared target178

Medical side effects []

165 side effects listed on drug labels in (midazolam).

  • Tenderness
  • Injection site pain
  • Somnolence
  • Drowsiness
  • Hiccups
  • Pain
  • Nausea
  • Vomiting
  • Agitation
  • Excitement
  • Hyperkinesia
  • Hypoxia
  • Hypoventilation
  • Respiratory depression
  • Pulmonary function test decreased
  • Cough
  • Headache
  • Obstructive airways disorder
  • Rhonchi
  • Bradycardia
  • Sedation
  • Tranquillisation excessive
  • Laryngospasm
  • Pruritus
  • Urticaria
  • Welts
  • Dermatitis
  • Rash
  • Ventricular extrasystoles
  • Extrasystoles
  • Induration
  • Erythema
  • Phlebitis
  • Musculoskeletal stiffness
  • Sneezing
  • Nasopharyngitis
  • Rhinorrhoea
  • Aggression
  • Aggressive reaction
  • Argumentativeness
  • Retrograde amnesia
  • Anaphylactic shock
  • Anaphylactoid reaction
  • Anger
  • Anxiety
  • Apnoea
  • Physical assault
  • Injury
  • Asthenia
  • Fatigue
  • Ataxia
  • Athetosis
  • Mental disorder
  • Bronchospasm
  • Confusional state
  • Feeling abnormal
  • Connective tissue disorder
  • Constipation
  • Delirium
  • Delusion
  • Depression
  • Diplopia
  • Dizziness
  • Lightheadedness
  • Felt faint
  • Drooling
  • Dysarthria
  • Slurred speech
  • Osteoarthritis
  • Dyspnoea
  • Eye disorder
  • Multiple fractures
  • Fracture
  • Retching
  • Gastrointestinal disorder
  • Digestion impaired
  • Hallucination
  • Cardiac arrest
  • Cardiac disorder
  • Cardiac failure
  • Haematoma
  • Hostility
  • Hypercapnia
  • Carbon dioxide increased
  • Hypersensitivity
  • Hyperventilation
  • Hypotension
  • Hypotensive
  • Immune system disorder
  • Irritability
  • Lethargy
  • Mediastinal disorder
  • Dyskinesia
  • Movements involuntary
  • Movement disorder
  • Nervous system disorder
  • Nervousness
  • Tension
  • Nightmare
  • Nystagmus
  • Paraesthesia
  • Neuropathy peripheral
  • Psychotic disorder
  • Respiratory failure
  • Salivary hypersecretion
  • Shock
  • Sleep disorder
  • Stridor
  • Withdrawal syndrome
  • Swelling
  • Tachycardia
  • Thrombophlebitis
  • Thrombosis
  • Ventricular tachycardia
  • Toothache
  • Tremor
  • Tremor muscle
  • Syncope
  • Presyncope
  • Vertigo
  • Wheezing
  • Dry mouth
  • Yawning
  • Chills
  • Mood swings
  • Affect lability
  • Drug withdrawal syndrome
  • Muscular weakness
  • Skin necrosis
  • Skin exfoliation
  • Respiratory arrest
  • Skin disorder
  • Hypopnoea
  • Muscle twitching
  • Tachypnoea
  • Respiratory rate decreased
  • Nodal rhythm
  • Dyspepsia
  • Disorientation
  • Emotional disorder
  • Dysphoria
  • Anterograde amnesia
  • Clonic convulsion
  • Drug withdrawal convulsions
  • Euphoric mood
  • Miosis
  • Therapeutic response decreased
  • Dependence
  • Vision blurred
  • Difficulty focusing eyes
  • Depressed mood
  • Feeling hot
  • Disinhibition
  • Mean arterial pressure
  • Mean arterial pressure decreased
  • Application site pain
  • Instillation site pain
  • Visual impairment
  • Cardio-respiratory arrest
  • Upper airway obstruction
  • Local reaction
  • Clonus
  • Depressed level of consciousness
  • Injection site coldness
  • Dysphonia

Indications

  • Amnesia
  • Apprehension
  • Convulsion
  • Convulsive seizure
  • Distress
  • Drowsiness
  • Epilepsy
  • Insomnia
  • Laceration
  • Memory impairment
  • Short period

Subjective effects []

0xea / Midazolam []
Routes:
  • Intravenous (3.7 - 15mg)
Forms:
  • Maleate
Effects:
nervewing / Midazolam []
Pilz / Midazolam []
Routes:
  • Sublingual (7.5mg)
Source:
  • Galenika Flormidal 15mg Tablet
Indication:Effects:

Experience reports

Reddit

There are currently 1 trip reports involving midazolam on : []

 []

  • Australia: Midazolam is a Schedule 4.
  • Brazil: Midazolam is a B1.[4]
  • Canada: Midazolam is a Schedule IV.[5][6]
  • Germany: Midazolam is Prescription only/Anlage III.
  • New Zealand: Midazolam is a Class C.
  • United Kingdom: Midazolam is Prescription only.[7][8]
  • United States: Midazolam is a Schedule IV under the "Controlled Substances Act".[9][10]
  • European Union: Midazolam is Prescription only.[11]
  • Other: Midazolam is a SE: Förteckning IV, In general: ℞ (Prescription only).[12]

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 4192, Midazolam. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/4192
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Midazolam. UNII: R60L0SM5BC. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/R60L0SM5BC
  3. Ries RK. Principles of Addiction Medicine. Lippincott Williams & Wilkins. 2009.
  4. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
  5. Product information. Health Canada. 28 June 2004. https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=8457
  6. Health product highlights 2021: Annexes of products approved in 2021. Health Canada. 3 August 2022. https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/health-product-highlights-2021/appendices.html
  7. Buccolam 10 mg oromucosal solution - Summary of Product Characteristics (SmPC). (emc). 7 June 2022. https://www.medicines.org.uk/emc/product/7460/smpc
  8. Hypnovel 10mg in 2ml - Summary of Product Characteristics (SmPC). (emc). 16 February 2022. https://www.medicines.org.uk/emc/product/10948/smpc
  9. Seizalam- midazolam hydrochloride injection, solution. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb2381bf-984a-48a8-95c0-3017c34cc170
  10. Nayzilam- midazolam spray. DailyMed. 19 January 2023. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2b29422e-54d5-4a49-8522-e9cf752368c3
  11. Buccolam EPAR. European Medicines Agency. 5 September 2011. https://www.ema.europa.eu/en/medicines/human/EPAR/buccolam
  12. BUCCOLAM, Munhålelösning 2,5 mg. FASS.se. 21 October 2024. https://fass.se/health/product/20101020000064/fass-text

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 10:21:12
drugspromissing (no DrugsPRO reagent data)2026-11-20 10:21:08
erowidmissing (no Erowid substance of that name)2026-11-20 10:21:08
gsrsok2026-11-20 10:21:10
hmdbmissing (hmdb.ca refused automated access to HMDB0014821)2026-11-20 10:21:08
keggok2026-11-20 10:21:15
pubchemok2026-11-20 10:21:08
redditok2026-11-20 10:21:08
siderok2026-11-20 10:21:09
structureok2026-11-20 10:21:08
wikipediaok2026-11-20 10:21:09